Phase ii study of alisertib, a selective aurora a kinase inhibitor, in relapsed and refractory aggressive B- And T-cell non-Hodgkin lymphomas

  • Jonathan W. Friedberg
  • , Daruka Mahadevan
  • , Erin Cebula
  • , Daniel Persky
  • , Izidore Lossos
  • , Amit B. Agarwal
  • , Jung Ah Jung
  • , Richard Burack
  • , Xiaofei Zhou
  • , E. Jane Leonard
  • , Howard Fingert
  • , Hadi Danaee
  • , Steven H. Bernstein

Producción científica: Article › revisión exhaustiva

190 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Phase ii study of alisertib, a selective aurora a kinase inhibitor, in relapsed and refractory aggressive B- And T-cell non-Hodgkin lymphomas'. En conjunto forman una huella única.

Medicine and Dentistry